Skip to content

Evaluation of desensitization in patients with sesame anaphylaxis

Evaluation of sesame oral immunotherapy effect for desensitization in patients with sesame anaphylaxis

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181002041210N1
Enrollment
10
Registered
2018-10-18
Start date
2018-09-23
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sesame anaphylaxis. Anaphylactic shock due to adverse food reaction

Interventions

Intervention group:at first all patients receive two doses of omalizumaboral (anti IgE antibody)150 mg by subcutaneous injection 4 weeks before starting treatment and second dose at the begining of

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to No maximum

Inclusion criteria

Inclusion criteria: positive oral food challenge with consumption of sesame tahini(OGHAB HALVA company) in patient with sesame anaphylaxis history with or without positive skin prick,skin prick to prick or specific IgE sesame tests

Exclusion criteria

Exclusion criteria: age less than 4 years history of cardiovascular disease beta blocker or ACEI drug usage severe or uncontrolled asthma infectious or immune deficiency disease unwillingness of patient

Design outcomes

Primary

MeasureTime frame
Sesame anaphylaxis in oral food challenge. Timepoint: ?Evaluation of sesame anaphylaxis in the begining of the study(before intervention) and 4 months after the end of immunotherapy. Method of measurement: oral food challenge test.

Secondary

MeasureTime frame
Serum specific sesame immunoglobulin E level. Timepoint: in the begining of the study(before intervention) and 4 months after the end of immunotherapy. Method of measurement: ImmunoCAP specific IgE test.;Size of wheal in skin prick test. Timepoint: in the begining of the study(before intervention) and 4 months after the end of immunotherapy. Method of measurement: ruler.;Size of wheal in skin prick to prick test. Timepoint: in the begining of the study(before intervention) and 4 months after the end of immunotherapy. Method of measurement: ruler.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFereshteh Salari

Iran University of Medical Sciences

drfereshtehsalari@gmail.com+98 21 6435 2383

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026